Anteris Technologies (ASX:AVR) Revises Manufacturing Terms with Switchback

2 min read | July 30, 2025 02:25 PM AEST | By Team Kalkine Media

Anteris Technologies (ASX:AVR) Revises Manufacturing Terms with Switchback — Image source: shutterstock

Revised Agreement with Defined Scope and Term

The First Amended and Restated Master Services Agreement, finalised on July 28, provides detailed provisions governing Switchback Medical’s involvement in engineering, testing, and production services. These operations will adhere to regulatory and quality management protocols, guided by structured purchase orders and agreed pricing.

The agreement outlines a clear duration through March 2028, with automatic renewals for successive one-year terms. Termination provisions include a defined notice period, offering flexibility to both organisations.

Intellectual Property Licencing and Ownership Clauses

A key component of the revised agreement involves a limited, exclusive, revocable, and royalty-free licence granted by Anteris Technologies to Switchback Medical. This licence enables the use of specific intellectual property solely for product manufacturing activities within the term of the agreement.

Despite this licence, Anteris Technologies retains complete ownership of all test data, reports, and any newly developed intellectual property that arises through the collaboration, ensuring strategic control over technological advancements.

Regulatory Documentation and Filing Plans

As part of standard compliance procedures, Anteris Technologies will submit the agreement within its Form 10-Q filing for the quarter ending September 30, 2025. This approach supports transparency and aligns with regulatory disclosure norms for dual-listed entities such as those listed on both the ASX and NASDAQ.

What is the purpose of the amended agreement with Switchback Medical?
To continue and formalise manufacturing support for Anteris Technologies’ structural heart devices.

Who retains ownership of intellectual property and test data under this agreement?
Anteris Technologies retains all ownership of test data and any developed intellectual property.

When does the agreement expire and can it be renewed?
The agreement expires in March 2028 with automatic annual renewals unless terminated in advance.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.